Purine derivatives as kinase inhibitors

Details for Australian Patent Application No. 2003215325 (hide)

Owner Eli Lilly and Company

Inventors McLean, Johnathan Alexander; Malhotra, Sushant; Clayton, Joshua Ryan; Mendel, David; Reel, Jon Kevin; Henry, James Robert; Furness, Kelly Wayne; Burkholder, Timothy Paul; Engler, Thomas Albert; Marquart, Angela Lynn; Li, Yihong; Diefenbacher, Clive Gideon

Agent Spruson & Ferguson

Pub. Number AU-B-2003215325

PCT Number PCT/US03/05050

PCT Pub. Number WO2003/076442

Priority 60/362,245 05.03.02 US

Filing date 4 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 18 September 2008

International Classifications

C07D 487/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4355 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/5513 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 471/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 498/06 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/362,245 05.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003215325

18 September 2008 Application Accepted

  Published as AU-B-2003215325

9 October 2008 Corrigenda

  Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2003215325, under INID(72), correct the co inventor name to Berridge, Brian Raymond, Ruegg, Charles Edwards and Sullivan, John Morris

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215326-METHOD FOR CLEANING HOLLOW TUBING AND FIBERS

2003215324-SYSTEM AND METHOD FOR BROADBAND DIGITAL BROADCASTING